QQ客服 官方微博 反馈留言

	Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice
	Zhen, Yongzhan; Shang, Boyang; Liu, Xiujun; Lin, Yajun; Zhen, Yongsu
	2016
卷号	12期号:1页码:182-187
关键词	Apoptosis lidamycin multiple myeloma tumor inhibition
ISSN号	0973-1482
DOI	10.4103/0973-1482.146093
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6382091
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhen, Yongzhan,Shang, Boyang,Liu, Xiujun,et al. Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice[J],2016,12(1):182-187.
APA	Zhen, Yongzhan,Shang, Boyang,Liu, Xiujun,Lin, Yajun,&Zhen, Yongsu.(2016).Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice.,12(1),182-187.
MLA	Zhen, Yongzhan,et al."Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice".12.1(2016):182-187.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。